Insider Buy/Sell Details for the Biotechnology Industry — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1527)
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
145
Price
$18.33
Total Value
$2.66K
Shares Held After
154,208
% of Holdings
0.1%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
2,836
Price
$2.64
Total Value
$7.49K
Shares Held After
972,170
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
1,035
Price
$145.02
Total Value
$150.10K
Shares Held After
25,000
% of Holdings
4.0%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
1,897
Price
$143.55
Total Value
$272.31K
Shares Held After
26,035
% of Holdings
6.8%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
450
Price
$142.20
Total Value
$63.99K
Shares Held After
27,932
% of Holdings
1.6%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
100
Price
$141.83
Total Value
$14.18K
Shares Held After
28,382
% of Holdings
0.4%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
540
Price
$140.58
Total Value
$75.91K
Shares Held After
28,482
% of Holdings
1.9%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
3,140
Price
$139.57
Total Value
$438.26K
Shares Held After
29,022
% of Holdings
9.8%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
784
Price
$138.18
Total Value
$108.33K
Shares Held After
32,162
% of Holdings
2.4%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
2,054
Price
$137.61
Total Value
$282.64K
Shares Held After
32,946
% of Holdings
5.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
9,939
Price
$0.37
Total Value
$3.68K
Shares Held After
331,414
% of Holdings
2.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
139,686
Price
$0.37
Total Value
$51.68K
Shares Held After
4,657,664
% of Holdings
2.9%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
124,893
Price
$8.89
Total Value
$1.11M
Shares Held After
16,763,043
% of Holdings
0.7%
Dermata Therapeutics, Inc. (DRMA)
Scott Kathleen D. — Director
Shares
11
Price
$1.19
Total Value
$13.09
Shares Held After
0
% of Holdings
100.0%
Aura Biosciences, Inc. (AURA)
Gibney Anthony S — Chief Financial and Business Officer.
Shares
12,824
Price
$6.42
Total Value
$82.33K
Shares Held After
265,354
% of Holdings
4.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
9,890
Price
$23.81
Total Value
$235.49K
Shares Held After
57,095
% of Holdings
14.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,096
Price
$24.41
Total Value
$99.98K
Shares Held After
38,378
% of Holdings
9.6%
Arcutis Biotherapeutics, Inc. (ARQT)
LIN SUE-JEAN — Director
Shares
4,946
Price
$24.38
Total Value
$120.59K
Shares Held After
27,567
% of Holdings
15.2%
Stablecoin Development Corp (SDEV)
Kazley Michael John — Director
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Stablecoin Development Corp (SDEV)
Framework Ventures IV L.P. — 10% Owner
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Stablecoin Development Corp (SDEV)
R01 Fund LP — 10% Owner
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
100,000
Price
$17.37
Total Value
$1.74M
Shares Held After
1,412,058
% of Holdings
6.6%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
60,400
Price
$160.17
Total Value
$9.67M
Shares Held After
158,222
% of Holdings
27.6%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
6,657
Price
$16.39
Total Value
$109.08K
Shares Held After
232,457
% of Holdings
2.8%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
3,328
Price
$16.38
Total Value
$54.53K
Shares Held After
239,114
% of Holdings
1.4%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
3,329
Price
$16.39
Total Value
$54.56K
Shares Held After
242,442
% of Holdings
1.4%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
272,322
Price
$45.02
Total Value
$12.26M
Shares Held After
7,388,902
% of Holdings
3.6%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
9,086
Price
$45.02
Total Value
$409.05K
Shares Held After
245,728
% of Holdings
3.6%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
5,538
Price
$60.71
Total Value
$336.21K
Shares Held After
15,437
% of Holdings
26.4%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
96,000
Price
$0.04
Total Value
$4.32K
Shares Held After
93,389,560
% of Holdings
0.1%
CytomX Therapeutics, Inc. (CTMX)
Ogden Christopher — Chief Financial Officer
Shares
1,624
Price
$3.05
Total Value
$4.95K
Shares Held After
295,324
% of Holdings
0.5%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
100
Price
$31.46
Total Value
$3.15K
Shares Held After
135,209
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,191
Price
$31.05
Total Value
$68.03K
Shares Held After
135,309
% of Holdings
1.6%
Acumen Pharmaceuticals, Inc. (ABOS)
Porter Derrell — Director
Shares
6,460
Price
$2.35
Total Value
$15.15K
Shares Held After
48,300
% of Holdings
11.8%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
53,336
Price
$51.37
Total Value
$2.74M
Shares Held After
1,483,848
% of Holdings
3.5%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
59
Price
$27.94
Total Value
$1.65K
Shares Held After
81,600
% of Holdings
0.1%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
224
Price
$27.12
Total Value
$6.08K
Shares Held After
81,659
% of Holdings
0.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
4,062
Price
$450.00
Total Value
$1.83M
Shares Held After
16,953
% of Holdings
19.3%
Immunome Inc. (IMNM)
Rosett Max — Chief Financial Officer
Shares
60,000
Price
$18.23
Total Value
$1.09M
Shares Held After
54,037
% of Holdings
52.6%
Ocugen, Inc. (OCGN)
Johnson-Greene Treerita Essalima — Chief Financial Officer
Shares
21,000
Price
$1.23
Total Value
$25.83K
Shares Held After
521,000
% of Holdings
4.0%
Clearmind Medicine Inc. (CMND)
HRT FINANCIAL LP — 10% Owner
Shares
3,183
Price
$3.32
Total Value
$10.57K
Shares Held After
103,492
% of Holdings
3.0%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.19
Total Value
$10.19K
Shares Held After
17,592
% of Holdings
5.7%
Jazz Pharmaceuticals plc (JAZZ)
Smith Mark Douglas — Director
Shares
1,157
Price
$230.55
Total Value
$266.75K
Shares Held After
9,680
% of Holdings
10.7%
uniQure N.V. (QURE)
Potts Jeannette — Chief Legal Officer
Shares
5,237
Price
$27.67
Total Value
$144.91K
Shares Held After
133,246
% of Holdings
3.8%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
1,503
Price
$67.14
Total Value
$100.92K
Shares Held After
6,589
% of Holdings
18.6%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
88,737
Price
$66.62
Total Value
$5.91M
Shares Held After
8,092
% of Holdings
91.6%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
10,000
Price
$27.85
Total Value
$278.50K
Shares Held After
43,254
% of Holdings
18.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Goodrich Katherine — Director
Shares
2,954
Price
$62.08
Total Value
$183.38K
Shares Held After
2,233
% of Holdings
57.0%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
1,928
Price
$62.94
Total Value
$121.35K
Shares Held After
106,786
% of Holdings
1.8%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
10,572
Price
$61.97
Total Value
$655.15K
Shares Held After
108,714
% of Holdings
8.9%
Showing 351–400 of 1527 transactions (page 8 of 31)